These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34474740)

  • 1. Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy: JACC Review Topic of the Week.
    Panza JA; Chrzanowski L; Bonow RO
    J Am Coll Cardiol; 2021 Sep; 78(10):1068-1077. PubMed ID: 34474740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Katikireddy CK; Samim A
    Clin Cardiol; 2022 Feb; 45(2):152-161. PubMed ID: 35077580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model.
    Rizzello V; Schinkel AF; Bax JJ; Boersma E; Bountioukos M; Vourvouri EC; Krenning B; Agricola E; Roelandt JR; Poldermans D
    Am J Cardiol; 2003 Jun; 91(12):1406-9. PubMed ID: 12804724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Viability and Revascularization: Current Understanding and Future Directions.
    Patel P; Ivanov A; Ramasubbu K
    Curr Atheroscler Rep; 2016 Jun; 18(6):32. PubMed ID: 27115143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy.
    Auerbach MA; Schöder H; Hoh C; Gambhir SS; Yaghoubi S; Sayre JW; Silverman D; Phelps ME; Schelbert HR; Czernin J
    Circulation; 1999 Jun; 99(22):2921-6. PubMed ID: 10359737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of myocardial viability assessment.
    Iskander S; Iskandrian AE
    Am J Cardiol; 1999 Mar; 83(5):696-702, A7. PubMed ID: 10080421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of revascularization to improve left ventricular function.
    Patel HC; Ellis SG
    Heart Fail Clin; 2015 Apr; 11(2):203-14. PubMed ID: 25834970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
    Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
    Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of myocardial viability in contemporary cardiac practice.
    Jamiel A; Ebid M; Ahmed AM; Ahmed D; Al-Mallah MH
    Heart Fail Rev; 2017 Jul; 22(4):401-413. PubMed ID: 28577280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathy.
    Rizzello V; Poldermans D; Biagini E; Schinkel AF; Elhendy A; Leone AM; Crea F; Maat A; Roelandt JR; Bax JJ
    Am J Cardiol; 2005 Aug; 96(3):386-9. PubMed ID: 16054464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
    Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.